News about Global Pharma

FDA Approves Nasal Spray Influenza Vaccine for Caregiver Administration

FluMist is approved for preventing influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age.

Global Pharma | 21/09/2024 | By Aishwarya |  932

Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive Chairman

Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO business (2020-22).

Global Pharma | 21/09/2024 | By Aishwarya |  842

AbbVie Gets Positive CHMP Opinion for Mirvetuximab Soravtansine

AbbVie has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of mirvetuximab soravtansine (ELAHERE).

Global Pharma | 21/09/2024 | By Aishwarya |  604

Lupin Gets FDA Approval for Bumetanide Injection

Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multiple-Dose Vials are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.

Global Pharma | 20/09/2024 | By Aishwarya |  692

Lifecore Biomedical's Isolator Filler Now GMP-Ready and Operational

Lifecore is now positioned to offer existing and future customers the speed and aseptic isolation benefits of this state-of-the-art technology for fill/finish services for prefilled syringes, vials, and cartridges.

Global Pharma | 20/09/2024 | By Aishwarya |  406

Aurobindo to Fully Acquire GLS Pharma for INR 22.5 Crore

The company entered into a binding agreement with GLS Pharma Ltd. and its promoters for the acquisition of the remaining 5,90,361 equity shares of INR 10 each amounting to a 49 percent stake for a purchase consideration of INR 22.5 crore.

Global Pharma | 19/09/2024 | By Aishwarya |  807

Seran Bioscience Announces USD 200 Million Strategic Growth Transaction

The new facility will be completed in 2026 and will support oral, pulmonary, and nasal delivery modalities with commercial-scale particle engineering solutions, including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, as well as comprehensive finished dose capabilities.

Global Pharma | 18/09/2024 | By Aishwarya |  580

Sanofi Begins Shipping BEYFORTUS in US

Sanofi has started shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its vaccines for children program.

Global Pharma | 18/09/2024 | By Aishwarya |  501

Merck Signs MoU with Siemens to Accelerate Digital Transformation Technology

The MoU makes Siemens a preferred global supplier and strategic partner for Smartfacturing technologies, paving the way for transformative projects across Merck's three business sectors.

Global Pharma | 18/09/2024 | By Aishwarya |  690

Piramal Pharma Gets SBTi Approval for its GHG Emission Reduction Targets

Piramal Pharma Ltd. has committed to reduce absolute scope 1 and 2 GHG emissions 42 percent by FY2030 from a FY2022 base year.

Global Pharma | 17/09/2024 | By Aishwarya |  549